Neumora Therapeutics Inc (NMRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Operating Expenses | 76,646 | 63,822 | 60,074 | 114,004 | 56,864 |
| Operating Income | -76,646 | -63,822 | -60,074 | -114,004 | -56,864 |
| Other Income | 4,152 | 5,247 | 6,353 | 5,542 | 3,837 |
| Pre-tax Income | -72,494 | -58,575 | -53,721 | -108,462 | -53,027 |
| Income Tax | 53 | 125 | N/A | N/A | N/A |
| Net Income Continuous | -72,547 | -58,700 | -53,721 | -108,730 | -53,027 |
| Net Income | $-72,547 | $-58,700 | $-53,721 | $-108,730 | $-53,027 |
| EPS Basic Total Ops | -0.45 | -0.37 | -0.34 | 0.01 | -1.14 |
| EPS Basic Continuous Ops | -0.45 | -0.37 | -0.34 | 0.00 | -1.14 |
| EPS Diluted Total Ops | -0.45 | -0.37 | -0.34 | 0.01 | -1.14 |
| EPS Diluted Continuous Ops | -0.45 | -0.37 | -0.34 | 0.00 | -1.14 |
| EPS Diluted Before Non-Recurring Items | -0.45 | -0.37 | -0.34 | N/A | N/A |
| EBITDA(a) | $-77,816 | $-65,827 | $-61,063 | $-114,511 | $-57,727 |